Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis
V. Cottin, J. Lacronique, L. Denis, P. Jaffray, C. Khouatra, R. Guelminger, D. Valeyre, H. Nunes, J. Bienvenu, B. Crestani, C. Taillé, J. F. Cordier (Lyon, Paris, Bobigny, France)
Source: Annual Congress 2011 - Rare diffuse lung diseases
Session: Rare diffuse lung diseases
Session type: Thematic Poster Session
Number: 627
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cottin, J. Lacronique, L. Denis, P. Jaffray, C. Khouatra, R. Guelminger, D. Valeyre, H. Nunes, J. Bienvenu, B. Crestani, C. Taillé, J. F. Cordier (Lyon, Paris, Bobigny, France). Diagnostic value of serum VEGF-D in consecutive patients with lymphangioleiomyomatosis. Eur Respir J 2011; 38: Suppl. 55, 627
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Serum VEGF-D and VEGFR-3 are biomarkers in lymphangioleiomyomatosis for its diagnosis and impaired pulmonary function Source: Annual Congress 2011 - Rare diffuse lung diseases Year: 2011
Diagnostic value of linear combination of CYFRA 21-1 and carcinoembryonic antigen in malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
The correlation between mediastinal lymphadenopathy positivity proved by mediastinoscopy and serum levels of vascular endothelial growth factor (VEGF) and carcinoembryonic antigen (CEA) in NSCLC cases Source: Annual Congress 2007 - Diagnosis of thoracic malignancies Year: 2007
Diagnostic utility of CYFRA 21-1 and carcinoembryonic antigen as a tumour markers in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Utility of serum soluble mesothelin as a follow-up marker in patients with malignant pleural mesothelioma Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007
Relationship between serum VEGF and tuberculous patients and non-tuberculousis mycobacterium patients Source: Eur Respir J 2003; 22: Suppl. 45, 341s Year: 2003
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 528s Year: 2004
The diagnostic value of serum tumor markers in newly diagnosed lung cancer patients Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
The diagnostic value of serum soluble CD 14 and IL-10 levels in newly diagnosed pulmonary tuberculosis patients and the relationship with disease extensity Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Diagnostic utility of pleural CEA and CYFRA 21-1 for malignant pleural effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003
Clinical evaluation of NSE, CYFRA 21-1, CEA and MCA at patients (pts.) with metastatic pleural effusion (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 448s Year: 2005
Diagnostic and prognostic significance of survivin levels in malignant pleural effusion Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Diagnostic role of d-dimer in suspected pulmonary embolism patients Source: Eur Respir J 2001; 18: Suppl. 33, 252s Year: 2001
Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer with malignant pleural effusions Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology Year: 2012
Clinical value of mediastinoscopy in the diagnosis of sarcoidosis: an analysis of 68 cases Source: Eur Respir J 2004; 24: Suppl. 48, 175s Year: 2004
Diagnostic value of procalcitonin and C-reactive protein in the differentiation among bening and malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009
Vascular endothelial growth factors and matrix metalloproteinases serum levels for LAM diagnosis in patients with sporadic LAM and tuberous sclerosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018
Diagnostic and prognostic value of a diagnostic CT regression model in suspected pulmonary hypertension Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside Year: 2019
Diagnostic value of NT-proBNP levels in differentiation of cardiac origin of pleural effusions Source: Annual Congress 2008 - Pleural effusion Year: 2008